Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II StudyJean Louis Lefèbvre, É. Bardet, Y. Pointreau et al.|Journal of Clinical Oncology|2013Cited by 418
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trialJ. Guigay, Franck Darloy, Cédrik Lafond et al.|The Lancet Oncology|2021Cited by 231